| Literature DB >> 31345184 |
Nan Ye1, Yurong Yuan1, Lei Xu2, Riccardo E Pfister3, Chuanzhong Yang4.
Abstract
BACKGROUND: The current standard treatment of neonates with intestinal perforation is surgery. However, the mortality rate after surgical treatment for intestinal perforation is very high for very low birth weight (VLBW) and extremely low birth weight (ELBW) neonates. In this review, conservative treatment of pneumoperitoneum among VLBW and ELBW neonates is investigated.Entities:
Keywords: Conservative treatment; ELBW; Intestinal perforation; Pneumoperitoneum; VLBW
Year: 2019 PMID: 31345184 PMCID: PMC6657043 DOI: 10.1186/s12887-019-1641-1
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Fig. 1The management strategies of conservative treatment
Fig. 2Flow chart of cases included
Fig. 3Diagnostic X-rays of pneumoperitoneum in all 8 cases
Demographics and follow-up of case series
| Case1 | Case2 | Case3 | Case4 | Case5 | Case6 | Case7 | Case8 | Median/Percentage | |
|---|---|---|---|---|---|---|---|---|---|
| Gender | M | F | F | F | F | F | M | M | |
| GA(W) | 27+ 2 | 31+ 6 | 26+ 6 | 24+ 6 | 25+ 5 | 24+ 3 | 29+ 4 | 29+ 1 | 27+ 1 |
| BW(g) | 800 | 1440 | 910 | 690 | 700 | 650 | 1160 | 1300 | 855 |
| Antenatal steroid | – | + | – | – | – | – | + | + | 38% |
| Max Milk intake (ml/kg/d) | 9 | 5.5 | 16.8 | 5.8 | 28.5 | 12.3 | 6.9 | 12.3 | 10.7 |
| Antenatal infection | + | + | + | + | – | – | – | – | 50% |
| Vaginal/CS | V | CS | V | V | V | V | CS | V | CS 25% |
| Asphyxia at birth | + | + | + | + | + | + | + | – | 88% |
| Res support | nIMV | Hiflow | nIMV | nIMV | nIMV | nIMV | SIMV | Hiflow | |
| hsPDA | + | – | + | + | – | + | – | + | 63% |
| ibuprofen | + | – | + | + | – | + | – | – | 50% |
| Antibiotics useda | PT + M | PT + M | PT + M | PT + M + F | PT + M | PT + M | PT + M | PT + M + F | |
| WBC(×10^9/l) | 24.9 | 13.2 | 44.1 | 29.0 | 19.5 | 38.9 | 6.6 | 38.9 | |
| Neutrophil (%) | 54.4 | 64.9 | 69.5 | 49.1 | 75.9 | 68.5 | 34.5 | 72.1 | |
| CRP | < 0.5 | 75.7 | < 0.5 | 1.2 | 0.9 | 35.3 | 2.1 | 9.9 | |
| Postnatal day of discovering perforation | 8 | 5 | 8 | 10 | 7 | 10 | 5 | 6 | 8 |
| X-ray normalisation after discovery (day) | 10 | 13 | 12 | 7 | 17 | 6 | 7 | 5 | 9 |
| Postnatal day of start feeding | 31 | 25 | 28 | 40 | 36 | 47 | 26 | 26 | 30 |
| Fasting time | 23 | 20 | 20 | 30 | 29 | 37 | 21 | 20 | 22 |
| Postnatal day of full feed | 60 | 50 | 68 | 155 | 73 | 149 | 50 | 58 | 64 |
| Postnatal day of discharge | 90 | 53 | 69 | 178 | 105 | 153 | 52 | 59 | 80 |
aPT Piperacillin-tazobactam, M Meropenem, F Fluconazole
Clinical features of the neonates underwent surgery
| Case A | Case B | Case C | Case D | Case E | |
|---|---|---|---|---|---|
| Gender | F | M | F | M | F |
| GA(W) | 27+ 2 | 27 | 30+ 3 | 30 | 24+ 3 |
| BW(g) | 1000 | 1060 | 1400 | 1130 | 640 |
| Antenatal steroid | + | + | – | + | + |
| Max Milk intake (ml/kg/d) | 15.3 | 0.5 | 1.5 | 4 | 1 |
| Antenatal infection | + | + | – | – | – |
| Vaginal/CS | V | V | CS | CS | V |
| Asphyxia at birth | – | – | – | – | – |
| Res support | nIMV | nCPAP | Hiflow | nIMV | SIMV |
| WBC(×10^9/l) | 14.4 | 11.5 | 9.4 | 12.6 | 38.3 |
| Neutrophil (%) | 62.5 | 65.6 | 35.2 | 49 | 71.3 |
| CRP (mg/L) | 175 | 0.5 | < 1 | < 0.5 | 3.03 |
| Postnatal day of discovering perforation | 39 | 3 | 3 | 9 | 8 |
| Postnatal day of transferring to surgery | 39 | 3 | 3 | 31 | 45 |
| Pathology | NEC | SIP | GP | Intestinal obstruction after perforation | Intestinal obstruction after perforation |
| Result of surgery | Abandoned treatment during operation | improved | improved | improved | improved |